173 related articles for article (PubMed ID: 21430234)
1. Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase.
Xiao Y; Shinkyo R; Guengerich FP
Drug Metab Dispos; 2011 Jun; 39(6):944-6. PubMed ID: 21430234
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
Guengerich FP; Johnson WW
Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
[TBL] [Abstract][Full Text] [Related]
3. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
4. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
Yamazaki H; Ueng YF; Shimada T; Guengerich FP
Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128
[TBL] [Abstract][Full Text] [Related]
5. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain.
Estabrook RW; Shet MS; Fisher CW; Jenkins CM; Waterman MR
Arch Biochem Biophys; 1996 Sep; 333(1):308-15. PubMed ID: 8806785
[TBL] [Abstract][Full Text] [Related]
6. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
[TBL] [Abstract][Full Text] [Related]
7. Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5.
Yamazaki H; Johnson WW; Ueng YF; Shimada T; Guengerich FP
J Biol Chem; 1996 Nov; 271(44):27438-44. PubMed ID: 8910324
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of indole by cytochrome P450 enzymes.
Gillam EM; Notley LM; Cai H; De Voss JJ; Guengerich FP
Biochemistry; 2000 Nov; 39(45):13817-24. PubMed ID: 11076521
[TBL] [Abstract][Full Text] [Related]
9. P450BM-3: reduction by NADPH and sodium dithionite.
Peterson JA; Boddupalli SS
Arch Biochem Biophys; 1992 May; 294(2):654-61. PubMed ID: 1567220
[TBL] [Abstract][Full Text] [Related]
10. Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase.
Guengerich FP; Martin MV; Sohl CD; Cheng Q
Nat Protoc; 2009; 4(9):1245-51. PubMed ID: 19661994
[TBL] [Abstract][Full Text] [Related]
11. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
Bonina TA; Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning, bacterial expression and functional characterisation of cytochrome P450 monooxygenase, CYP97C27, and NADPH-cytochrome P450 reductase, CPR I, from Croton stellatopilosus Ohba.
Sintupachee S; Ngamrojanavanich N; Sitthithaworn W; De-Eknamkul W
Plant Sci; 2014 Dec; 229():131-141. PubMed ID: 25443840
[TBL] [Abstract][Full Text] [Related]
13. High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein.
Fisher CW; Shet MS; Caudle DL; Martin-Wixtrom CA; Estabrook RW
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10817-21. PubMed ID: 1438282
[TBL] [Abstract][Full Text] [Related]
14. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
Jenkins CM; Waterman MR
Biochemistry; 1998 Apr; 37(17):6106-13. PubMed ID: 9558349
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Purification of Recombinant Rat NADPH-P450 Reductase by Using a Hexahistidine-Tag.
Park HG; Lim YR; Han S; Jeong D; Kim D
J Microbiol Biotechnol; 2017 May; 27(5):983-989. PubMed ID: 28274101
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
17. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
[TBL] [Abstract][Full Text] [Related]
18. Redox cycling of resorufin catalyzed by rat liver microsomal NADPH-cytochrome P450 reductase.
Dutton DR; Reed GA; Parkinson A
Arch Biochem Biophys; 1989 Feb; 268(2):605-16. PubMed ID: 2464338
[TBL] [Abstract][Full Text] [Related]
19. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
[TBL] [Abstract][Full Text] [Related]
20. Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1.
Nishida CR; Lee M; de Montellano PR
Mol Pharmacol; 2010 Sep; 78(3):497-502. PubMed ID: 20566689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
